Creative Medical Technology Holdings Inc (CELZ) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Creative Medical Technology Holdings Inc

NASDAQ | CELZ

2.13

USD

-0.11 (-4.91%)

AT CLOSE (AS OF Apr 4, 2025)

$5.7M

MARKET CAP

P/E Ratio

-3.71

EPS

$6.9

52 Week High

$1.9

52 Week Low

LIFE SCIENCES

Sector

CELZ Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

CELZ Technicals

Tags:

CELZ Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$5.4K
Total Revenue	$9K
Cost Of Revenue	$3.6K
Costof Goods And Services Sold	$3.6K
Operating Income	-$5.6M
Selling General And Administrative	$3.6M
Research And Development	$2M
Operating Expenses	$5.6M
Investment Income Net	-
Net Interest Income	$303K
Interest Income	$303K
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$56K
Income Before Tax	-$5.3M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$5.3M
Comprehensive Income Net Of Tax	-$5.3M
Ebit	-$5.6M
Ebitda	-$5.6M
Net Income	-$5.3M

Revenue & Profitability

Earnings Performance

CELZ Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$11M
Total Current Assets	$10M
Cash And Cash Equivalents At Carrying Value	$3.5M
Cash And Short Term Investments	$3.5M
Inventory	$6.6K
Current Net Receivables	-
Total Non Current Assets	$649K
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$649K
Intangible Assets Excluding Goodwill	$649K
Goodwill	-
Investments	$6.5M
Long Term Investments	-
Short Term Investments	$6.5M
Other Current Assets	$277K
Other Non Current Assets	-
Total Liabilities	$371K
Total Current Liabilities	$371K
Current Accounts Payable	$317K
Deferred Revenue	$40K
Current Debt	-
Short Term Debt	$14K
Total Non Current Liabilities	-
Capital Lease Obligations	-
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$14K
Other Current Liabilities	$54K
Other Non Current Liabilities	-
Total Shareholder Equity	$10M
Treasury Stock	$271K
Retained Earnings	-$59M
Common Stock	$1.4K
Common Stock Shares Outstanding	$1.4M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	-$8M
Payments For Operating Activities	$0
Proceeds From Operating Activities	-
Change In Operating Liabilities	-$3M
Change In Operating Assets	-$112K
Depreciation Depletion And Amortization	$0
Capital Expenditures	$100K
Change In Receivables	-
Change In Inventory	-$3.6K
Profit Loss	-$5.3M
Cashflow From Investment	$3.4M
Cashflow From Financing	-$271K
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	$271K
Payments For Repurchase Of Equity	$271K
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$0
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$0
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$5.3M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$5.4K
Total Revenue	$9K
Cost Of Revenue	$3.6K
Costof Goods And Services Sold	$3.6K
Operating Income	-$5.6M
Selling General And Administrative	$3.6M
Research And Development	$2M
Operating Expenses	$5.6M
Investment Income Net	-
Net Interest Income	$303K
Interest Income	$303K
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$56K
Income Before Tax	-$5.3M
Income Tax Expense	$0
Interest And Debt Expense	-
Net Income From Continuing Operations	-$5.3M
Comprehensive Income Net Of Tax	-$5.3M
Ebit	-$5.6M
Ebitda	-$5.6M
Net Income	-$5.3M

CELZ Profile

Creative Medical Technology Holdings Inc Profile

Sector: LIFE SCIENCES

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company is headquartered in Phoenix, Arizona.

Symbol	Price	Change %	Market Cap	Volume
NVDA	$94.14	-7.53%	$2.68T	411,170,358
MULN	$0.08	-0.25%	$422.46K	337,586,718
DMN	$0.01	-9.93%	-	250,076,428
WCT	$0.28	45.18%	$100.86M	188,340,447
TSLA	$240.53	-10.01%	$909.50B	142,548,074

Symbol	Price	Change %	Market Cap	Volume
JNJ	$154.10	-3.58%	$399.65B	8,937,614
PG	$165.33	-4.10%	$399.61B	7,816,658
ABBV	$188.93	-6.31%	$364.89B	7,519,295
NVO	$62.56	-6.77%	$308.32B	8,022,008
ABT	$124.98	-5.06%	$228.39B	6,215,349

Symbol	Price	Change %	Market Cap	Volume
AEHL	$4.37	8,224.00%	$3.18M	9,081,262
SOBR	$5.18	1,390.92%	$396.44K	1,133,038
FTFT	$1.35	948.14%	$3.27M	173,315
CISS	$4.00	592.64%	$2.68M	439,024
AREB	$10.90	175.25%	$3.77M	75,956,361

Symbol	Price	Change %	Market Cap	Volume
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644
KRBP	$0.16	-48.72%	$424.82K	107,749

Quick Links

CELZ $2.13 (-4.91%) Quote details